4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-007548
Chief Scientific Officer sold 15,580 shares at an average $57.74 ($899,602)
- Chief Scientific Officer acquired 15,580 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2021-02-01 | Option exercise | +7,790 | $6.32 | $49,233 | 8,469 | D: show line 1 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-02-01 | Sale | −4,200 | $55.54 | $233,268 | 4,269 | D: show line 2 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-02-01 | Sale | −3,590 | $56.18 | $201,686 | 679 | D: show line 3 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-02-02 | Option exercise | +7,790 | $6.32 | $49,233 | 8,469 | D: show line 4 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-02-02 | Sale | −2,910 | $58.76 | $170,992 | 5,559 | D: show line 5 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-02-02 | Sale | −2,501 | $59.80 | $149,560 | 3,058 | D: show line 6 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-02-02 | Sale | −2,379 | $60.57 | $144,096 | 679 | D: show line 7 in the form |
| Open-market sales · 15,580 sh · avg $57.74 · $899,602 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2021-02-01 | Option exercise · Stock Option (Right to Buy) | −7,790 | 202,540 | D: show line 8 in the form | ||
| ROBINS HARLAN S Chief Scientific Officer | 2021-02-02 | Option exercise · Stock Option (Right to Buy) | −7,790 | 194,750 | D: show line 9 in the form |
Loading xslF345X03/doc4.xml…